Zydus to launch Semaglutide Injection in India on patent expiry

A key differentiator of Zydus’ offering is its indigenously developed delivery device

Zydus to launch Semaglutide Injection in India on patent expiry
A key differentiator of Zydus’ offering is its indigenously developed delivery device

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Economist Admin Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.